FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RemedyRepack Carbamazepine 200 mg Tablets Recall

Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: Re…

RemedyRepack Inc. · Indiana, PA

Risk level
Class II
Reported by FDA
Jul 22, 2020
Recall ID
D-1387-2020
Check your lot numberHow we source this data

Summary

RemedyRepack recalled Carbamazepine 200 mg Tablets starting Jun 29, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1387-2020 on Jul 22, 2020. Reason: FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing. Status: Terminated.

Why it was recalled

FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.

Product description

Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2489-00 for box; 70518-2489-01 per unit dose.

Lot numbers, UPCs & expiration codes

Lot #: B0796217-020920, Exp. Date: 02/28/2021

Where it was sold

Product was distributed to MN.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1387-2020
Classification
Class II
Status
Terminated
Recall initiated
Jun 29, 2020
FDA report date
Jul 22, 2020
Quantity
498 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
RemedyRepack Inc.

Original FDA data

Every field from FDA enforcement report D-1387-2020, exactly as published.

Show all FDA fields
City
Indiana
State
PA
Status
Terminated
Country
United States
Event ID
86006
Address
625 Kolter Dr Ste 4
Code information
Lot #: B0796217-020920, Exp. Date: 02/28/2021
Postal code
15701-3571
Report date
Jul 22, 2020
Product type
Drugs
Recall number
D-1387-2020
Classification
Class II
Recalling firm
RemedyRepack Inc.
Product quantity
498 tablets
Termination date
Sep 14, 2020
Reason for recall
FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2489-00 for box; 70518-2489-01 per unit dose.
Distribution pattern
Product was distributed to MN.
Recall initiation date
Jun 29, 2020
Initial firm notification
Letter
Center classification date
Jul 14, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1387-2020, published Jul 22, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls